AGP Executive Report
Last update: 6 hours agoJapan Health Policy: Japan will revise its disaster management plan to better protect evacuees from heatstroke and cold, including stockpiling water and shade gear after last year’s long tsunami evacuations that led to hospital visits. Medical Workforce: A Japan health ministry survey finds 15% of doctors still log over 960 hours of overtime annually, with surgery, OB-GYN and emergency departments most affected. Infectious Disease: A phase 3 trial reports ensitrelvir post-exposure prophylaxis cuts lab-confirmed COVID risk among household contacts (2.9% vs 9.0% by day 10) with no new safety issues. Cancer Research: Japanese researchers report a frog-bacterium strain that eliminated bowel cancer tumors in mice after a single dose, with effects tied to direct tumor damage and immune activation. Public Health & Drugs: Japan logged a record 7,120 cannabis-related investigations in 2025, with most suspects under 30, as authorities also reported rising cannabis seizures. AI & Security: Japan hurriedly redraws its AI strategy after six months, aiming for “AI sovereignty” and tighter security against cyber risks. Clinical/Regulatory: FDA approved LEQEMBI IQLIK (lecanemab-irmb) subcutaneous initiation dosing for early Alzheimer’s disease. Healthcare Access/Privacy: Japan’s amended data protection law allows disclosure of medical histories without consent to support AI and statistics.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
